Chemistry Analyzer and Reagents Keesler AFB

The Defense Health Agency is seeking to procure chemistry analyzers, immunoassay analyzers, and an automated specimen track system for the Department of Clinical Laboratory and Pathology Services at Keesler Air Force Base Medical Center in Mississippi. The solicitation requires vendors to provide two floor-standing integrated clinical chemistry/immunoassay analyzers capable of processing a comprehensive test menu of 588,843 annual results across multiple categories including general chemistry, immunochemistry, urine drugs of abuse, therapeutic drugs, and cardiac tests. The contract includes all necessary maintenance services, supplies, reagents, and training required for automated specimen processing, with systems requiring an approved Authorization to Operate (ATO) and full interoperability with the Cerner Military Health System Genesis Lab Information System. The solicitation utilizes a Cost Per Reportable Result (CPRR) pricing structure and mandates comprehensive service provisions including 24/7 customer support, emergency repairs, and on-site technical support within 24-48 hours of initial contact. The original response deadline was extended from June 30, 2025, to July 23, 2025, providing potential vendors additional time to prepare their proposals.

This procurement opportunity does not include any set-aside designations and is open to all qualified contractors. The contract structure includes a base period from October 1, 2025, to September 30, 2026, with four optional one-year extensions, potentially extending the total contract period through September 2030. The solicitation includes two Contract Line Item Numbers (CLINs) covering chemistry services and equipment delivery/installation, with pricing attachments showing extensive categories of laboratory tests though specific dollar amounts are not disclosed in the current documentation. Performance will take place at Keesler Air Force Base Medical Center in Biloxi, Mississippi, with vendors required to provide comprehensive installation including a 36-foot track system with multiple components such as I/O modules, centrifuge, power panels, and designated areas for water and power connections. The procurement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and emphasizes strict cybersecurity compliance requirements through a detailed Medical Device and Equipment Risk Assessment form.